6 hasil untuk "Robbert G.M. Bredius"
Menampilkan 1–6 · 1,98 detik · RSS
-
Artikel Jurnal Teks lengkap
Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
The implementation of newborn screening for severe combined immunodeficiency (SCID) in the Netherlands is a multifaceted process in which several parties are involved. The Dutch Ministry of Health adopted the advice of the Dutch Health Council to include SCID in the Dutch newborn screening program…
-
Artikel Jurnal
Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?
Antithymocyte globulin (ATG) is a widely accepted part of the conditioning regimen applied in the setting of hematopoietic stem cell transplantation (HSCT) to prevent graft rejection and graft-versus-host disease. Although weight-based dosing of ATG has been introduced to optimize ATG dosing…
-
Artikel Jurnal
Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study
Anti T-lymphocyte globulin (ATLG) is used in hematopoietic stem cell transplantation (HSCT) to prevent graft-versus-host disease (GvHD) and graft failure. To date, insight in ATLG pharmacokinetics and -dynamics (PK/PD) is limited, and population PK (POPPK) models are lacking. In this prospective…
-
Artikel Jurnal Teks lengkap
Second-tier genetics improves newborn screening accuracy for SCID and other T cell deficienciesSecond-tier genetics in TREC-based NBS
This study demonstrates that second-tier genetics improves newborn screening accuracy for SCID and other T cell deficiencies. A safety net algorithm maintains high sensitivity for SCID while substantially increasing the PPV from 22.1% to 55.2%.
-
Artikel Jurnal Teks lengkap
Managing non-SCID T cell lymphopenia after TREC-based newborn screeningNon-SCID T cell lymphopenia after TREC-based NBS
TREC-based NBS detects many secondary findings and additional causes for T cell lymphopenia other than SCID. The clinical follow-up of these newborns poses a new challenge for pediatric immunologists. We present clinical follow-up data of 6.5 years of NBS for SCID, underscoring the importance of…